News News
CME CME
Clinical Guidance Clinical Guidance

Log In Log In
Log Out Log Out

News News
CME CME
Clinical Guidance Clinical Guidance

Specialties

Choose a specialty

All Specialties Allergy/Asthma Cardiac/Vascular Intervention Cardiology Dermatology Endocrinology Gastroenterology Hematology/Oncology Hepatology Infectious Disease Nephrology Neurology Ophthalmology Optometry Orthopedics Pediatrics Primary Care Psychiatry Pulmonology Rheumatology Women's Health & OB/GYN
Home
Headline News
Meeting News
Podcasts
Blogs & Columns
Resources

All Specialties
Allergy/Asthma
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Women's Health & OB/GYN

All Specialties News Subspecialties

Blogs & Columns

Account Account

Log Out Log Out

Sitemap

Sitemap
2010
April
18

April 18, 2010 Articles

Filter by Available Specialty

All Specialties

Filter by specialty

All Specialties Hematology/Oncology

BATTLE: Biopsy-mandated study in NSCLC feasible
Erlotinib approved as maintenance therapy for NSCLC
Next-generation sequencing identified mutations that affect panitumumab response
TGF-beta2 inhibitor has clinical benefit in high-grade gliomas

Play on Healio

Follow Healio

Twitter
Facebook
Instagram
Threads
LinkedIn

About

About Healio About Healio
About the Wyanoke Group About the Wyanoke Group
Editorial Policy and Philosophy Editorial Policy and Philosophy
Sitemap Sitemap

Account Information

My Account Login
My Account My Account
Help Help
Email Subscriptions Email Subscriptions
Email Subscriptions Email Subscriptions Unknown
Newspaper and Journal Subscriptions Newspaper and Journal Subscriptions

Contact Us

Email Us Email Us
Contact Newsroom Contact Newsroom
Advertising Information Advertising Information
Permissions and Reprints Permissions and Reprints

Legal

Do Not Sell My Personal Information Do Not Sell My Personal Information
Terms and Conditions Terms and Conditions
Medical Disclaimer Medical Disclaimer
Privacy Policy Privacy Policy

Sign Up for Email

Get the latest news and education delivered to your inbox

Email address

Enter your email

Update email address

Specialty

Update email address

The email address associated with your Healio account is:

If you would like to edit or change the email address that your subscriptions and alerts are sent to, use the "Update email address" link.

Update email address

© Healio All Rights Reserved.

We’re sorry, but an unexpected error has occurred.

Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.

Would you like to receive email reminders to complete your saved activities from Healio CME?

Yes

No

Activity saved! You'll receive reminders to complete your saved activities from Healio CME.